Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Chlorogenic acid (CGA) is a key component in Aidi injection, known for its anti-cancer properties and ability to reduce toxicity. Therefore, accurate detection of CGA levels in Aidi injection is essential for monitoring therapeutic efficacy and minimizing adverse effects. This study presents a rapid and simple fluorescent method for detecting CGA in Aidi injection using aggregation-induced emission (AIE) nanoclusters, i.e. D(-)-penicillamine (DPA)-capped bimetallic gold/copper nanoclusters (DPA-Au/CuNCs). Upon the addition of CGA, the aggregation state of DPA-Au/CuNCs was disrupted through hydrogen bond formation and ligand exchange, leading to fluorescence quenching. The prepared DPA-Au/CuNCs exhibited a rapid response time of 0.5 min, and demonstrated good sensitivity for CGA, with a limit of detection of 3.75 μg/mL, and a linear detection range of 12.5-200 μg/mL. This method was successfully applied for the analysis of CGA in Aidi injection and plasma with good recovery rates and minimal matrix effect, highlighting its potential for the applications in pharmaceutical products and clinical samples.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpba.2024.116570 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating the Aidi injection mechanism for low-grade glioma based on the network pharmacology approach, The Cancer Genome Atlas (TCGA), and molecular docking technology.
Medicine (Baltimore)
August 2025
Pharmacy Intravenous Admixture Service, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Low-grade glioma (LGG) can affect any part of the central nervous system. This study aimed to investigate the mechanism of Aidi injection (AIDI) in treating LGG using network pharmacology, The Cancer Genome Atlas, and molecular docking technology. Open databases were used to obtain AIDI targets and components as well as LGG genes.
View Article and Find Full Text PDFBeneficial effects of proprietary Chinese medicines as adjuvant therapy in patients with advanced colorectal cancer: A meta-analysis.
Medicine (Baltimore)
August 2025
Department of Orthopedics, Lu'an Hospital of Traditional Chinese Medicine Affiliated to Anhui University of Chinese Medicine, Lu'an, Anhui Province, China.
Background: In the clinical management of advanced colorectal cancer, traditional Chinese patent medicines or their simple preparations are commonly combined with conventional chemotherapy; however, robust comparative evidence on efficacy and safety across regimens is lacking. Because the submission system does not allow relabeling the section heading, we have clarified this change here.
Methods: Randomized controlled trials investigating the use of traditional Chinese patent medicines and simple preparations in combination with conventional chemotherapy for the treatment of advanced colorectal cancer were searched in the following databases: CNKI, Wanfang, VIP, PubMed, Cochrane Library, Embase, and Web of Science.
Early combined conbercept and dexamethasone implant therapy for diabetic macular edema.
Int Ophthalmol
June 2025
Department of Ophthalmology, Chengdu AiDi Eye Hospital, Chengdu, 610000, Sichuan, China.
Aim: This study evaluated the clinical effectiveness and safety of a combined dexamethasone implant (Ozurdex) with Conbercept injections for diabetic macular edema (DME).
Methods: A prospective case-control clinical trial was conducted on 46 DME patients. Patients were randomly assigned to either the combination group, receiving Conbercept injections followed by Ozurdex (24 patients) using a 2 + 1 + 1 + PRN protocol, or the monotherapy group, receiving only Conbercept injections (22 patients) following a 5 + PRN protocol.
[Integrated multiomics reveal mechanism of Aidi Injection in attenuating doxorubicin-induced cardiotoxicity].
Zhongguo Zhong Yao Za Zhi
April 2025
State Key Laboratory of Functions and Applications of Medicinal Plants/Guizhou Provincial Key Laboratory of Pharmaceutics,Guizhou Medical University Guiyang 550004, China Engineering Research Center for the Development and Application of Ethnic Medicine and TCM(Ministry of Education),Guizhou Provinci
The combination of Aidi Injection(ADI) and doxorubicin(DOX) is a common strategy in the treatment of cancer, which can achieve synergistic anti-tumor effects while attenuating the cardiotoxicity caused by DOX. This study aims to investigate the mechanism of ADI in attenuating DOX-induced cardiotoxicity by multi-omics. DOX was used to induce cardiotoxicity in mice, and the cardioprotective effects of ADI were evaluated based on biochemical indicators and pathological changes.
View Article and Find Full Text PDFImmune regulation and clinical response of Chinese herbal injections combined with TACE in hepatocellular carcinoma: a cumulative logit regression and Bayesian network meta-analysis.
Front Med (Lausanne)
April 2025
Department of Radiotherapy, Tianjin First Central Hospital, Tianjin, China.
Objectives: This study evaluated the immunomodulatory effects and clinical efficacy of Chinese herbal injections (CHIs) combined with transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients using cumulative logit regression and Bayesian network meta-analysis.
Methods: A systematic review of 48 randomized controlled trials (RCTs) involving 4,293 HCC patients was conducted using PubMed, Cochrane Library, EMBASE, Scopus, and Google Scholar. Outcomes included immune markers (CD3+, CD4+, CD8+, CD4+/CD8+ ratio, and NK cells), clinical response rate, and overall survival (6-month, 1-year, and 2-year).